Pharmacologic intervention for cancer-related dyspnea

Journal of Clinical Oncology

Volumn 26, Issue 25, 2008, Pages 4225-

  Cuervo Pinna, Miguel Ángel ^a   Vargas, Rafael Mota ^a   Redondo Moralo, María José ^a   Sánchez Correas, Miguel Ángel ^a  

^a Regional Palliative Care Program of Extremadura   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; FENTANYL CITRATE; MIDAZOLAM; MORPHINE; OPIATE;

ADD ON THERAPY; ADVANCED CANCER; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; DRUG ACTIVITY; DRUG EFFECT; DYSPNEA; HUMAN; INFORMATION RETRIEVAL; LETTER; PRIORITY JOURNAL; SEDATION; SOMNOLENCE; TERMINALLY ILL PATIENT; TREATMENT OUTCOME;

ANALGESICS, OPIOID; CHLORPROMAZINE; DYSPNEA; FENTANYL; HUMANS; NEOPLASMS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TERMINAL CARE;

EID: 51649090934     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.3566     Document Type: Letter

References (7)

1. Ben-Aharon I, Gafter-Gvili A, Paul M, et al: Interventions for alleviating cancer-related dyspnea: A systematic review. J Clin Oncol 26:2396-2404, 2008
2. O'Neil PA, Morton PB, Stara RD: Chlorprmazine: A specific effect on breathlessness? Br J Clin Pharmacol 19:793-797, 1985
3. McIver B, Walsh D, Nelson K: The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage 9:341-345, 1994
4. Cuervo Pinna MA, Mota Vargas R, Redondo Moralo MJ, et al: Etiology factors of the dyspnea at the end of life. Med Pal 15:143-148, 2008
5. Navigante AH, Cerchietti LC, Castro MA, et al: Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 31:38-47, 2006
6. Man GC, Hsu K, Sproule BJ: Effects of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest 90:832-836, 1986
7. Allard P, Lamontagne C, Bernard P, et al: How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage 17:256-265, 1999